![Weiguo Ye](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Weiguo Ye
President at Beijing Continent Pharmaceutical Co., Ltd.
Profile
Wei Guo Ye is currently the President & Director at Beijing Continent Pharmaceutical Co., Ltd.
He is also the National-Sales Director at Simcere Pharmaceutical Co. Ltd.
Additionally, he holds the position of Executive Vice President at Continent Pharmaceutical Inc. and Chief Operating Officer at Gyre Therapeutics, Inc. In the past, Mr. Ye worked as the Director-Sales at Jiangsu Simcere Pharmaceutical Co., Ltd.
He also served as the Regional Manager-Sales at Shanghai Roche Pharmaceuticals Ltd.
and as the Vice President-Marketing at Hubei Mengyang Pharmaceutical Co Ltd.Mr. Ye completed his undergraduate studies at Peking University and holds an MBA from China Europe International Business School.
Weiguo Ye active positions
Companies | Position | Start |
---|---|---|
Continent Pharmaceutical Inc.
![]() Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Corporate Officer/Principal | 2016-11-30 |
Beijing Continent Pharmaceutical Co., Ltd.
![]() Beijing Continent Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Continent Pharmaceutical Co. Ltd. is a commercial-stage biopharmaceutical company committed to the research, development and commercialization of innovative drugs for organ fibrosis for two decades. The firm focuses on idiopathic pulmonary fibrosis (“IPF”) and have gradually broadened therapeutic field and research & development efforts to other areas of organ fibrosis. The company flagship product ETUARY (pirfenidone capsule) was approved in China in 2011 and is among the first three approved drugs for IPF worldwide. The firm has developed a pipeline of additional four innovative drug candidates, and amassed eight-years’ experience of successful commercialization. The company was founded in July 2002 and is headquartered in Beijing, China. | President | 2023-03-31 |
Simcere Pharmaceutical Co. Ltd. | Corporate Officer/Principal | - |
Former positions of Weiguo Ye
Companies | Position | End |
---|---|---|
Shanghai Roche Pharmaceuticals Ltd.
![]() Shanghai Roche Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Shanghai Roche Pharmaceuticals Ltd. is a Chinese company that develops, manufactures, and distributes anti-cancer and virus drugs. The company is based in Shenchang, China. | Sales & Marketing | - |
Jiangsu Simcere Pharmaceutical Co., Ltd.
![]() Jiangsu Simcere Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1995, Jiangsu Simcere Pharmaceutical Co., Ltd. is a subsidiary of Jiangsu Simcere Medical Diagnostics Co., Ltd. The company is based in Nanjing, China. The Chinese company manufactures and sells pharmaceutical products. | Sales & Marketing | - |
Hubei Mengyang Pharmaceutical Co Ltd. | Sales & Marketing | - |
Training of Weiguo Ye
Peking University | Undergraduate Degree |
China Europe International Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 6 |
---|---|
Jiangsu Simcere Pharmaceutical Co., Ltd.
![]() Jiangsu Simcere Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1995, Jiangsu Simcere Pharmaceutical Co., Ltd. is a subsidiary of Jiangsu Simcere Medical Diagnostics Co., Ltd. The company is based in Nanjing, China. The Chinese company manufactures and sells pharmaceutical products. | Health Technology |
Continent Pharmaceutical Inc.
![]() Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Health Technology |
Shanghai Roche Pharmaceuticals Ltd.
![]() Shanghai Roche Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Shanghai Roche Pharmaceuticals Ltd. is a Chinese company that develops, manufactures, and distributes anti-cancer and virus drugs. The company is based in Shenchang, China. | Health Technology |
Beijing Continent Pharmaceutical Co., Ltd.
![]() Beijing Continent Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Continent Pharmaceutical Co. Ltd. is a commercial-stage biopharmaceutical company committed to the research, development and commercialization of innovative drugs for organ fibrosis for two decades. The firm focuses on idiopathic pulmonary fibrosis (“IPF”) and have gradually broadened therapeutic field and research & development efforts to other areas of organ fibrosis. The company flagship product ETUARY (pirfenidone capsule) was approved in China in 2011 and is among the first three approved drugs for IPF worldwide. The firm has developed a pipeline of additional four innovative drug candidates, and amassed eight-years’ experience of successful commercialization. The company was founded in July 2002 and is headquartered in Beijing, China. | Health Technology |
Simcere Pharmaceutical Co. Ltd. | |
Hubei Mengyang Pharmaceutical Co Ltd. |
- Stock Market
- Insiders
- Weiguo Ye